Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study

References

• CDC. Measles (Rubeola). [accessed 2019 November 11]. https://www.cdc.gov/measles/hcp/index.html.
   Google Scholar
• CDC. Measles, mumps, and rubella (MMR) vaccine safety. [accessed 2018 Sep 15]. https://www.cdc.gov/vaccinesafety/vaccines/mmr-vaccine.html.
   Google Scholar
• Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM. An economic analysis of the current universal 2-dose Measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004;189(Suppl 1):S131–45. doi:10.1086/378987.
   PubMed Web of Science ®Google Scholar
• Dabbagh A, Patel MK, Dumolard L, Gacic-Dobo M, Mulders MN, Okwo-Bele JM, Kretsinger K, Papania MJ, Rota PA, Goodson JL. Progress towards regional Measles elimination – worldwide, 2000–2016. Wkly Epidemiol Rec. 2017;92:649–59.
   PubMedGoogle Scholar
• WHO. Mumps reported cases. 2019 July 15 (data received as of 1-July-19) [accessed 2019 November 10]. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencemumps.html.
   Google Scholar
• Griffin DE. The immune response in measles: virus control, clearance and protective immunity. Viruses. 2016 Oct 12;8(10):282. doi:10.3390/v8100282.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Eur J Public Health. 2012 Feb;22(1):133–39. doi:10.1093/eurpub/ckq134.
   PubMed Web of Science ®Google Scholar
• CDC. The pink book. Epidemiology and Prevention of Vaccine-Preventable Diseases. Measles; accessed 2019 October 31]. https://www.cdc.gov/vaccines/pubs/pinkbook/meas.html.
   Google Scholar
• Griffin DE. Measles vaccine. Virun Immunol. 2018;31(2):86–95. doi:10.1089/vim.2017.0143.
   PubMed Web of Science ®Google Scholar
• D’Ancona F, D’Amario C, Maraglino F, Rezza G, Ricciardi W, Iannazzo S. Introduction of new and reinforcement of existing compulsory vaccinations in Italy: first evaluation of the impact on vaccination coverage in 2017. Euro Surveill. 2018;23(22). doi:10.2807/1560-7917.ES.2018.23.22.1800238.
   Google Scholar
• Lopalco PL, Prato R, Pastore R, Martinelli D, Caputi G, Germinario C. Epidemiological analysis of measles in the Apulian region based on the use of current data sources. J Prev Med Hyg. 2005;46:132.
   Google Scholar
• Prato R, Chironna M, Caputi G, Sallustio A, Martinelli D, Falco A, Germinario CA. An outbreak of measles in Apulia, Italy, November 2006 – January 2007. Euro Surveill. 2007 Apr 5;12(14):E070405.1.
   Google Scholar
• Caputi G, Tafuri S, Chironna M, Martinelli D, Sallustio A, Falco A, Germinario CA, Prato R, Quarto M. An outbreak of measles including nosocomial transmission in Apulia, south-east Italy, January-March 2008 - a preliminary report. Euro Surveill. 2008 Apr 17;13(16):18839.
   PubMedGoogle Scholar
• Tafuri S, Germinario C, Rollo M, Prato R. Occupational risk from measles in healthcare personnel: a case report. J Occup Health. 2009;51(1):97–99. doi:10.1539/joh.N8006. Epub 2008 Dec 19.
   PubMed Web of Science ®Google Scholar
• Tafuri S, Gallone MS, Gallone MF, Pappagallo MT, Larocca AMV, Germinario C. Monitoring the process of measles elimination by serosurveillance data: the Apulian 2012 study. Vaccine. 2016;34(18):2092–95. doi:10.1016/j.vaccine.2016.03.011.
   PubMed Web of Science ®Google Scholar
• Gallone MS, Germinario C, Larocca AMV, Tafuri S. Long time immunogenicity of measles vaccine in the vaccination era: an open question. Hum Vaccin Immunother. 2017;13(1):117–19. doi:10.1080/21645515.2016.1227519.
   PubMed Web of Science ®Google Scholar
• DiaSorin. The diagnostic specialist. LIAISON® Measles IgG and IgM. The fully automated solution for antibody detection. [accessed 2019 Nov 12]. https://www.diasorin.com/sites/default/files/allegati_prodotti/ese_brochure_liaison_Measles_0413_low.pdf
   Google Scholar
• Cabrillo College. Clinical compliance basics. Health screening. Measles, mumps, rubella (MMR). [Last accessed 2019 November 04]. https://www.cabrillo.edu/services/health/clinical-compliance/clinical-mumps.html.
   Google Scholar
• Bianchi FP, Gallone MS, Gallone MF, Larocca AMV, Vimercati L, Quarto M, Tafuri S. HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: an Italian study among medical students. J Viral Hepat. 2018;26:136–44. doi:10.1111/jvh.13001.
   PubMed Web of Science ®Google Scholar
• Bianchi FP, Stefanizzi P, De Nitto S, Larocca AMV, Germinario C, Tafuri S. Long-term immunogenicity of measles vaccine: an Italian retrospective cohort study. J Infect Dis. 2020;221(5):721–28.
   Web of Science ®Google Scholar
• Bianchi FP, Mascipinto S, Stefanizzi P, de Nitto S, Germinario CA, Lopalco P, Tafuri S. Prevalence and management of measles susceptibility in healthcare workers in Italy: a systematic review and meta-analysis. Expert Rev Vaccines. 2020 Jul;19(7):611–20. doi:10.1080/14760584.2020.1791091.
   PubMed Web of Science ®Google Scholar
• Anichini G, Gandolfo C, Fabrizi S, Miceli GB, Terrosi C, Gori Savellini G, Prathyumnan S, Orsi D, Battista G, Cusi MG. Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy. Vaccines (Basel). 2020 Feb 3;8(1):66. doi:10.3390/vaccines8010066.
   PubMed Web of Science ®Google Scholar
• Christenson B, Böttiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine. 1994;12(2):129–33. doi:10.1016/0264-410X(94)90049-3.
   PubMed Web of Science ®Google Scholar
• Ruckdeschel JC, Graziano KD, Mardiney MR Jr. Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol. 1975;17(1):11–18. doi:10.1016/S0008-8749(75)80002-5.
   PubMed Web of Science ®Google Scholar
• Kawada T, Suzuki S. Validation study on self-reported height, weight, and blood pressure. Percept Mot Skills. 2005 Aug;101( no. 1):187–91. doi:10.2466/pms.101.1.187-191.
   PubMed Web of Science ®Google Scholar
• Gilbert GH, Rose JS, Shelton BJ. A prospective study of the validity of data on self‐reported dental visits. Community Dent Oral Epidemiol. 2002;30(5):352–62. doi:10.1034/j.1600-0528.2002.00062.x.
   PubMed Web of Science ®Google Scholar
• Short ME, Goetzel RZ, Pei X, Tabrizi MJ, Ozminkowski RJ, Gibson TB, Dejoy DM, Wilson MG. How accurate are self-reports? Analysis of self-reported health care utilization and absence when compared with administrative data. J Occup Environ Med. 2009;51(7):786–96. doi:10.1097/JOM.0b013e3181a86671.
   PubMed Web of Science ®Google Scholar
• Trevisan A, Frasson C, Morandin M, Beggio M, Bruno A, Davanzo E, Di Marco L, Simioni L, Amato G. Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease. Infect Control Hosp Epidemiol. 2007;28(5):564–69. doi:10.1086/516657.
   PubMed Web of Science ®Google Scholar
• Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Am J Infect Control. 2006;34(9):583–87. doi:10.1016/j.ajic.2006.04.213.
   PubMed Web of Science ®Google Scholar
• Amanna IJ, Carlson NE, Slifka MK. Duration of umoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357:1903–15. doi:10.1056/NEJMoa066092.
   PubMed Web of Science ®Google Scholar
• Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, van Binnendijk RS. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214(12):1980–86. doi:10.1093/infdis/jiw480. Epub 2016 Oct 7.
   PubMed Web of Science ®Google Scholar
• Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204 Suppl 1:S559–63. doi:10.1093/infdis/jir098.
   PubMed Web of Science ®Google Scholar
• Stefanizzi P, Stella P, Ancona D, Malcangi KN, Bianchi FP, De Nitto S, Ferorelli D, Germinario CA, Tafuri S. Adverse events following measles-mumps-rubella-varicella vaccination and the case of seizures: a post marketing active surveillance in Puglia Italian region, 2017-2018. Vaccines (Basel). 2019;7(4). doi:10.3390/vaccines7040140.
   PubMed Web of Science ®Google Scholar
• Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, Siljander H, Rewers M, Choy DF, Wilson MS, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019;366(6465):599–606. doi:10.1126/science.aay6485.
   PubMed Web of Science ®Google Scholar
• WHO. Measles elimination field guide. [accessed 2019 November 12]. https://apps.who.int/iris/rest/bitstreams/920747/retrieve.
   Google Scholar
• Kurata T, Kanbayashi D, Egawa K, Kinoshita M, Yoshida H, Miyazono M, Motomura K. A measles outbreak from an index case with immunologically confirmed secondary vaccine failure. Vaccine. 2020 Feb 5;38(6):1467–75. doi:10.1016/j.vaccine.2019.11.075.
   Web of Science ®Google Scholar
• Stephen E, Kitengeso RE, Kiria GT, Felician N, Mwema GG, Mafarasa AP. A mathematical model for control and elimination of the transmission dynamics of measles. Appl Comput Maths. 2015;4(6):396–408. doi:10.11648/j.acm.20150406.12.
   Google Scholar
• Bianchi FP, Vimercati L, Mansi F, De Nitto S, Stefanizzi P, Rizzo LA, Fragnelli GR, Cannone ESS, De Maria L, Larocca AMV, et al. Compliance with immunization and a biological risk assessment of health care workers as part of an occupational health surveillance program: the experience of a university hospital in southern Italy. Am J Infect Control. 2020 Apr;48(4):368–74. doi:10.1016/j.ajic.2019.09.024.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Dinca I, Apfel F, Cecconi S, Wűrz A, Takacs J, Suk J, Celentano LP, Kramarz P, Larson HJ. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. 2016 Sep 22;34(41):5013–20. doi:10.1016/j.vaccine.2016.08.029.
   PubMed Web of Science ®Google Scholar
• Giri P, Basu S, Farrow D, Adisesh A. Cost-effectiveness analysis of MMR immunization in health care workers. Occup Med (Lond). 2013;63:422–24.
   PubMed Web of Science ®Google Scholar